Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Capital Expenditures (2020 - 2026)

Viatris (VTRS) posted Capital Expenditures of $52.8 million for Q2 2026, up 32.33% on a QoQ basis from $39.9 million in Q1 2026, and little changed year-over-year from $52.9 million in Q2 2025.

Analysis

Viatris (VTRS) Capital Expenditures (2020 - 2026) Analysis & Trends

Viatris has reported Capital Expenditures for 7 years, with the latest figure at $52.8 million in Q2 2026.

  • On a quarterly basis, Capital Expenditures changed 0.19% year-over-year to $52.8 million in Q2 2026; TTM through Jun 2026 was $376.0 million, a 20.17% increase from a year earlier, with the FY2025 full-year figure at $378.8 million, up 16.2% from the prior year.
  • Capital Expenditures was $52.8 million for Q2 2026 at Viatris, up from $39.9 million in the prior quarter.
  • The five-year high for Capital Expenditures was $196.5 million in Q4 2025, with the low at $39.9 million in Q1 2026.
  • Average Capital Expenditures over 5 years is $87.8 million, with a median of $72.4 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2025: Capital Expenditures decreased 25.89% in 2023, then soared 39.96% in 2025.
  • Over 5 years, Capital Expenditures stood at $153.7 million in 2022, then climbed by 7.68% to $165.5 million in 2023, then retreated by 15.17% to $140.4 million in 2024, then soared by 39.96% to $196.5 million in 2025, then plunged by 73.13% to $52.8 million in 2026.
  • The last three Capital Expenditures figures came in at $52.8 million (Q2 2026), $39.9 million (Q1 2026), and $196.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 104.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 52.80 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -36.19 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 30.70 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 77.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -27.87 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 3.05 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 8.59 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.80 Mn
Mar 31, 2026 39.90 Mn
Dec 31, 2025 196.50 Mn
Sep 30, 2025 86.80 Mn
Jun 30, 2025 52.90 Mn
Mar 31, 2025 42.60 Mn
Dec 31, 2024 140.40 Mn
Sep 30, 2024 77.00 Mn
Jun 30, 2024 58.80 Mn
Mar 31, 2024 49.80 Mn
Dec 31, 2023 165.50 Mn
Sep 30, 2023 95.90 Mn
Jun 30, 2023 67.80 Mn
Mar 31, 2023 47.80 Mn
Dec 31, 2022 153.70 Mn
Sep 30, 2022 103.90 Mn
Jun 30, 2022 83.90 Mn
Mar 31, 2022 64.50 Mn
Dec 31, 2021 197.40 Mn
Sep 30, 2021 121.00 Mn